摘要
长链非编码RNA ( long non-coding RNA, LncRNA)是一类转录本长度超过200 nt的RNA分子,由RNA聚合酶Ⅱ( RNA polymeraseⅡ)加工合成,是基因组序列转录生成的产物。近年来,随着高通量技术的不断发展,越来越多的LncRNA逐渐被发现并成为研究热点。 LncRNA作为新兴分子标志物与肿瘤的发生、发展机制密切相关。目前运用于功能性LncRNA筛查的分子高通量新一代测序方法高效且节源,并广泛应用于基因检测。 RNA-seq、 RIP-seq及CLIP-Seq此3种高通量测序在LncRNA中的研究运用已经报道,文章旨在深入探讨技术特点以帮助发掘肿瘤分子标志物。
Long non-coding RNAs ( LncRNAs) are non-protein coding transcripts longer than 200 nucleotides. They are processed and synthesized by RNA polymerase Ⅱ. Numerous LncRNAs have been found recently with the development of high-throughput sequencing technique and they have become a hotspot of research. LncRNAs as emerging molecular markers are closely associated with the occurrence and development of tumors. The new generation sequencing method ( high-through sequencing) is efficient and energy-saving for screening LncRNAs. RNA-seq, RIP-seq and CLIP-Seq have been reported to sequence the LncRNAs. In this review, we discuss the features of these techniques in order to help identify the molecular markers of tumors.
出处
《医学分子生物学杂志》
CAS
2016年第3期178-182,共5页
Journal of Medical Molecular Biology
关键词
高通量技术
测序
肿瘤
长链非编码RNA
long non-coding RNA
high-throughput techniques
sequencing
tumor